Nurix Therapeutics IncNASDAQ:NRIX
- LAST PRICE22.2000
- TODAY'S CHANGE (%)0.5300 (2.4458%)
- Bid / Lots20.6800/ 1
- Ask / Lots25.0000/ 10
- Open / Previous Close21.8600 / 21.6700
- Day Range
- 52 Week Range
- Volume435,581
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | NRIX |
|---|---|---|
| 09:32 ET | 6304 | 21.945 |
| 09:34 ET | 100 | 22.005 |
| 09:36 ET | 303 | 22.12 |
| 09:38 ET | 15544 | 22.4 |
| 09:39 ET | 250 | 22.365 |
| 09:41 ET | 15000 | 22.35 |
| 09:43 ET | 100 | 22.365 |
| 09:52 ET | 1364 | 22.61 |
| 09:54 ET | 1305 | 22.46 |
| 09:56 ET | 300 | 22.36 |
| 09:59 ET | 607 | 22.205 |
| 10:01 ET | 100 | 22.16 |
| 10:03 ET | 750 | 22.1 |
| 10:08 ET | 100 | 22.15 |
| 10:10 ET | 700 | 22.155 |
| 10:14 ET | 100 | 22.14 |
| 10:15 ET | 735 | 22.2799 |
| 10:17 ET | 208 | 22.295 |
| 10:19 ET | 300 | 22.31 |
| 10:24 ET | 300 | 22.245 |
| 10:26 ET | 200 | 22.18 |
| 10:28 ET | 200 | 22.24 |
| 10:30 ET | 300 | 22.16 |
| 10:32 ET | 550 | 22.17 |
| 10:33 ET | 800 | 22.21 |
| 10:35 ET | 100 | 22.26 |
| 10:37 ET | 317 | 22.32 |
| 10:39 ET | 200 | 22.345 |
| 10:42 ET | 200 | 22.37 |
| 10:44 ET | 200 | 22.34 |
| 10:46 ET | 1694 | 22.37 |
| 10:48 ET | 2552 | 22.375 |
| 10:50 ET | 400 | 22.29 |
| 10:51 ET | 200 | 22.37 |
| 10:53 ET | 100 | 22.46 |
| 10:55 ET | 200 | 22.45 |
| 10:57 ET | 200 | 22.44 |
| 11:00 ET | 467 | 22.495 |
| 11:02 ET | 100 | 22.495 |
| 11:06 ET | 200 | 22.54 |
| 11:08 ET | 100 | 22.49 |
| 11:09 ET | 100 | 22.52 |
| 11:11 ET | 200 | 22.5 |
| 11:13 ET | 400 | 22.49 |
| 11:15 ET | 100 | 22.48 |
| 11:18 ET | 200 | 22.41 |
| 11:20 ET | 500 | 22.41 |
| 11:22 ET | 200 | 22.31 |
| 11:24 ET | 400 | 22.28 |
| 11:27 ET | 600 | 22.24 |
| 11:31 ET | 400 | 22.35 |
| 11:33 ET | 200 | 22.32 |
| 11:36 ET | 600 | 22.36 |
| 11:38 ET | 400 | 22.35 |
| 11:40 ET | 400 | 22.35 |
| 11:42 ET | 928 | 22.35 |
| 11:44 ET | 200 | 22.36 |
| 11:45 ET | 100 | 22.345 |
| 11:47 ET | 700 | 22.33 |
| 11:49 ET | 100 | 22.27 |
| 11:51 ET | 200 | 22.23 |
| 11:54 ET | 200 | 22.26 |
| 11:56 ET | 785 | 22.36 |
| 11:58 ET | 100 | 22.3 |
| 12:02 ET | 200 | 22.35 |
| 12:03 ET | 100 | 22.42 |
| 12:05 ET | 500 | 22.37 |
| 12:07 ET | 500 | 22.44 |
| 12:09 ET | 100 | 22.485 |
| 12:12 ET | 100 | 22.47 |
| 12:16 ET | 100 | 22.48 |
| 12:18 ET | 200 | 22.47 |
| 12:21 ET | 200 | 22.4601 |
| 12:23 ET | 200 | 22.475 |
| 12:27 ET | 600 | 22.43 |
| 12:30 ET | 200 | 22.4 |
| 12:32 ET | 237 | 22.4447 |
| 12:36 ET | 226 | 22.42 |
| 12:38 ET | 100 | 22.43 |
| 12:39 ET | 300 | 22.46 |
| 12:41 ET | 100 | 22.51 |
| 12:43 ET | 566 | 22.5005 |
| 12:45 ET | 474 | 22.5017 |
| 12:48 ET | 200 | 22.54 |
| 12:50 ET | 3631 | 22.7 |
| 12:52 ET | 200 | 22.71 |
| 12:54 ET | 8926 | 22.77 |
| 12:56 ET | 780 | 22.765 |
| 12:57 ET | 1455 | 22.86 |
| 12:59 ET | 1700 | 22.87 |
| 01:01 ET | 1420 | 22.81 |
| 01:03 ET | 300 | 22.875 |
| 01:06 ET | 2160 | 22.9 |
| 01:08 ET | 2398 | 22.905 |
| 01:10 ET | 700 | 23 |
| 01:12 ET | 600 | 22.975 |
| 01:15 ET | 25200 | 23.01 |
| 01:17 ET | 800 | 23 |
| 01:19 ET | 1463 | 23.095 |
| 01:21 ET | 600 | 23.09 |
| 01:24 ET | 1300 | 23.12 |
| 01:28 ET | 600 | 23.1 |
| 01:30 ET | 508 | 23.065 |
| 01:32 ET | 100 | 23.055 |
| 01:33 ET | 500 | 23.12 |
| 01:35 ET | 7500 | 23.07 |
| 01:37 ET | 16388 | 22.81 |
| 01:39 ET | 1420 | 22.66 |
| 01:42 ET | 4175 | 22.7 |
| 01:44 ET | 600 | 22.66 |
| 01:48 ET | 200 | 22.63 |
| 01:50 ET | 200 | 22.545 |
| 01:51 ET | 800 | 22.51 |
| 01:53 ET | 600 | 22.465 |
| 01:55 ET | 900 | 22.49 |
| 02:00 ET | 300 | 22.52 |
| 02:02 ET | 263 | 22.5199 |
| 02:06 ET | 438 | 22.48 |
| 02:08 ET | 300 | 22.48 |
| 02:09 ET | 100 | 22.45 |
| 02:11 ET | 200 | 22.42 |
| 02:13 ET | 845 | 22.4 |
| 02:15 ET | 215 | 22.42 |
| 02:18 ET | 523 | 22.36 |
| 02:20 ET | 100 | 22.365 |
| 02:22 ET | 400 | 22.4 |
| 02:24 ET | 100 | 22.4 |
| 02:27 ET | 400 | 22.46 |
| 02:29 ET | 114 | 22.45 |
| 02:31 ET | 200 | 22.39 |
| 02:33 ET | 100 | 22.34 |
| 02:38 ET | 200 | 22.395 |
| 02:40 ET | 100 | 22.4 |
| 02:42 ET | 1000 | 22.385 |
| 02:44 ET | 248 | 22.4 |
| 02:45 ET | 100 | 22.38 |
| 02:47 ET | 200 | 22.4 |
| 02:49 ET | 100 | 22.3731 |
| 02:51 ET | 13231 | 22.48 |
| 02:54 ET | 555 | 22.51 |
| 02:58 ET | 100 | 22.485 |
| 03:00 ET | 777 | 22.52 |
| 03:02 ET | 100 | 22.495 |
| 03:03 ET | 2936 | 22.43 |
| 03:05 ET | 2700 | 22.41 |
| 03:07 ET | 2089 | 22.295 |
| 03:09 ET | 1720 | 22.29 |
| 03:12 ET | 1200 | 22.325 |
| 03:14 ET | 900 | 22.255 |
| 03:16 ET | 1210 | 22.2 |
| 03:18 ET | 600 | 22.24 |
| 03:20 ET | 964 | 22.215 |
| 03:21 ET | 800 | 22.22 |
| 03:23 ET | 1400 | 22.315 |
| 03:25 ET | 600 | 22.27 |
| 03:27 ET | 1000 | 22.2 |
| 03:30 ET | 1822 | 22.29 |
| 03:32 ET | 1092 | 22.29 |
| 03:34 ET | 2620 | 22.41 |
| 03:36 ET | 1489 | 22.41 |
| 03:38 ET | 900 | 22.41 |
| 03:39 ET | 2062 | 22.39 |
| 03:41 ET | 1905 | 22.42 |
| 03:43 ET | 1836 | 22.415 |
| 03:45 ET | 3700 | 22.435 |
| 03:48 ET | 2693 | 22.36 |
| 03:50 ET | 2700 | 22.26 |
| 03:52 ET | 3902 | 22.21 |
| 03:54 ET | 4432 | 22.2 |
| 03:56 ET | 4796 | 22.24 |
| 03:57 ET | 10657 | 22.15 |
| 03:59 ET | 65938 | 22.2 |
Sep 30, 2024
Nurix Therapeutics Announces Presentations at Discovery on Target Conference, from 7:00AM ET on Monday Sep 30, 2024 by Dow Jones
7:00AM ET on Monday Sep 30, 2024 by Dow Jones
Sep 6, 2024
Nurix Therapeutics To Participate in Upcoming ADC & Radiopharmaceuticals Pharma & Biotech Partnering Summit, from 7:00AM ET on Friday Sep 06, 2024 by Dow Jones
7:00AM ET on Friday Sep 06, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Nurix Therapeutics Inc | 1.4B | -7.6x | --- |
Immatics NV | 1.1B | -11.9x | --- |
Arvinas Inc | 1.7B | -4.7x | --- |
Arcus Biosciences Inc | 1.5B | -5.4x | --- |
Arcutis Biotherapeutics Inc | 1.2B | -4.6x | --- |
Gyre Therapeutics Inc | 1.3B | -15.6x | --- |
Company Information
Nurix Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of small molecules and antibody therapies based on the modulation of cellular protein levels as a treatment approach for cancer, inflammatory conditions and other diseases. It DELigase is an integrated discovery platform, to identify and advance drug candidates targeting E3 ligases. Its drug candidates include NX-2127, NX-5948 and NX-1607. NX-2127 is an orally bioavailable Brutons tyrosine kinase (BTK) degrader that also degrades cereblon neosubstrates IKZF1 (Ikaros) and IKZF3 (Aiolos) for the treatment of relapsed or refractory B-cell malignancies. NX-5948 is an orally bioavailable BTK degrader for the treatment of relapsed or refractory B-cell malignancies and potentially autoimmune diseases. NX-1607 is an oral clinical-stage small molecule drug candidate that inhibits Casitas B-lineage lymphoma proto-oncogene-B (CBL-B).
Contact Information
- Headquarters
- 1700 Owens St Ste 205SAN FRANCISCO, CA, United States 94158-0006
- Phone
- 415-660-5320
- Fax
- 415-525-4200
Executives
- Independent Chairman of the Board
- Julia Gregory
- President, Chief Executive Officer, Director
- Arthur Sands
- Chief Financial Officer
- Hans van Houte
- Chief Technical Officer
- Pasit Phiasivongsa
- Chief Scientific Officer
- Gwenn Hansen
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.4B |
|---|---|
Revenue (TTM) | $62.3M |
Shares Outstanding | 64.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.22 |
EPS | $-2.92 |
Book Value | $4.12 |
P/E Ratio | -7.6x |
Price/Sales (TTM) | 23.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -287.47% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
